Seattle Genetics snags early approval for advanced breast cancer drugThe FDA has approved Seattle Genetics’ breast cancer drug Tukysa (tucatinib) four months early, including in certain patients Share XSeattle Genetics snags early approval for advanced breast cancer drughttps://pharmaphorum.com/news/fda-approves-seattle-genetics-advanced-breast-cancer-drug/
